MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Synta Pharmaceuticals Corp. Company Profile (NASDAQ:SNTA)

Consensus Ratings for Synta Pharmaceuticals Corp. (NASDAQ:SNTA) (?)
Ratings Breakdown: 4 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.20)
Consensus Price Target: $3.17 (804.76% upside)

Analysts' Ratings History for Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
Show:
DateFirmActionRatingPrice TargetActions
10/21/2015JMP SecuritiesDowngradeMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Cowen and CompanyDowngradeOutperform -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015FBR & Co.DowngradeOutperform -> Market Perform$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Roth CapitalDowngradeBuy -> Neutral$13.00 -> $1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/10/2015MLV & Co.Reiterated RatingBuy$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/10/2015Canaccord GenuityInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/1/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha